Tim Orchard
Timothy Robin Orchard CBE is a British healthcare official who is chief executive of Imperial College Healthcare NHS Trust, one of the largest NHS Trusts in London. He is a consultant physician and Professor of gastroenterology at Imperial College London and is renowned for his ongoing research and teaching in the field of inflammatory bowel disease.
Under his leadership at the Trust, he has been a vocal campaigner for the rebuild of St Mary's Hospital which is part of the national 'New Hospital Programme'.[1][2] The Trust has the biggest backlog maintenance liability of any NHS organisation with an estimated £7m spent annually on repairs at St Mary's to stay operational.[3][4]
Early life
Orchard was born at Charing Cross Hospital at the former site on the Strand. Orchard was educated at Trinity School, an independent boys' school in Croydon.[5] Orchard's father was a gastroenterologist[6]. He undertook his undergraduate medical degree at Corpus Christi College, University of Cambridge and completed his clinical training at Charing Cross and Westminster Medical School.[7]
Inflammatory Bowel Disease (IBD) research
After completing medical school, Orchard was a research fellow at the University of Oxford with Professor Derek Jewell, and has continued his research interests in inflammatory bowel disease (IBD) and extra-intestinal manifestations (EIMs).[8]
During his academic career at Imperial College London, Orchard and his colleagues were part of an international effort to make better use of metabolic analysis and genetics in the treatment of inflammatory gut conditions like ulcerative colitis and Crohn's disease.[9] His research has contributed towards several national guidelines for the management of inflammatory bowel disease in adults[10], and to NICE guidelines on spondyloarthritis in the UK.
Career
Orchard joined Imperial College Healthcare NHS Trust as a registrar in 2000. He was later medical director and divisional director for medicine and integrated care. Orchard was appointed as the chief executive of Imperial College Healthcare in June 2018.[11] In 2023–24, Orchard was listed as one of the highest-paid Trust chief executives in the country.
During COVID-19, he led Imperial College Healthcare NHS Trust's five hospitals operationally through the pandemic, which involved reorganising services and staff to meet the demand of positive-covid cases.[12] He spoke publicly on the challenges faced by the Trust's hospitals during this period, including increasing ICU capacity with limited infrastructure and the rollout of personal protective equipment.[13]
He was also chair of The Shelford Group in 2023, a collaboration between ten of the largest teaching and research NHS hospital trusts in England.[14]
In October 2025, he was announced as the new incoming chief executive for the North West London acute NHS Trusts, which will be the biggest hospital group in England.[15]
References
- ↑ "St Mary's: Crumbling hospital must be rebuilt, Trust boss says". BBC News. Retrieved 2024-11-13.
- ↑ "Hospital seeking new 'funding models'". Camden New Journal. Retrieved 2026-02-16.
- ↑ Lydall, Ross (2021-09-16). "'Perfect storm' of more Covid, soaring A&E demand and staff exhaustion". The Standard. Retrieved 2024-11-13.
- ↑ Orchard, Tim (2023-08-02). "Hospitals are crumbling, and the impact on patients is immeasurable". New Statesman. Retrieved 2024-11-13.
- ↑ Yawar, Ali (2018-06-05). "Former Trinity student appointed chief executive of Imperial College Healthcare NHS Trust". Trinity School. Retrieved 2024-10-31.
- ↑ "Speaking from the gut: teaching awards and inaugural lecture | Imperial News". Imperial College London. 2015-11-26. Retrieved 2026-02-16.
- ↑ "Professor Tim Orchard". www.imperial.nhs.uk. Retrieved 2026-02-16.
- ↑ "Immune-Mediated Inflammatory Disease Forum". Immune-Mediated Inflammatory Disease Forum. Retrieved 2026-02-16.
- ↑ "Speaking from the gut: teaching awards and inaugural lecture | Imperial News". Imperial College London. 2015-11-26. Retrieved 2026-02-16.
- ↑ Mowat, Craig; Cole, Andrew; Windsor, Al; Ahmad, Tariq; Arnott, Ian; Driscoll, Richard; Mitton, Sally; Orchard, Tim; Rutter, Matt; Younge, Lisa; Lees, Charlie; Ho, Gwo-tzer; Satsangi, Jack; Bloom, Stuart; Gastroenterology, on behalf of the IBD Section of the British Society of (2011-05-01). "Guidelines for the management of inflammatory bowel disease in adults". Gut. 60 (5): 571–607. doi:10.1136/gut.2010.224154. ISSN 0017-5749. PMID 21464096.
- ↑ "Professor Tim Orchard". www.imperial.nhs.uk. Retrieved 2025-03-27.
- ↑ Campbell, Denis; editor, Denis Campbell Health policy (2020-10-01). "'On a knife-edge': NHS frontline prepares for a Covid second wave". The Guardian. ISSN 0261-3077. Retrieved 2024-11-13.
- ↑ "A tale of two hospitals: the pandemic and its aftermath in Berlin and London – with Professor Heyo Kroemer and Professor Tim Orchard". www.health.org.uk. Retrieved 2024-11-13.
- ↑ Info (2023-03-31). "New leadership arrangements for the Shelford Group - Shelford Group". shelfordgroup.org. Retrieved 2024-10-31.
- ↑ Discombe, Matt. "CEO announced for £4bn hospital group". Health Service Journal. Retrieved 2026-02-16.
This article "Tim Orchard" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Tim Orchard. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
